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Nitrogen utilization in uremic patients fed by continuous
nasogastric infusion
ELIAS ABRAS and MACKENZIE WALSER
Departments of Pharmacology and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Nitrogen utilization in uremic patients fed by continuous nasogastric
infusion. Patients with severe renal failure were continuously fed an
electrolyte-free solution containing oligosaccharides plus 35 g of a
mixture of six amino acids and four (or, in one study, five) nitrogen-free
analogues via a small-bore nasogastric tube attached to a pump. They
also ingested three small meals daily. Total caloric intake averaged 34
kcal/kg (of which 76% was infused). Total nitrogen intake averaged only
3.3 g (of which 68% was infused). Nevertheless, nitrogen balance was
positive (average + 1.22 g/day). All components of nitrogen excretion
fell to unusually low average values: urea nitrogen appearance, 1.14 g/
day; non-urea urinary nitrogen, 0.63 g/day; fecal nitrogen, 0.48 g/day.
Nitrogen requirement for balance on this regimen, estimated from linear
regression, was only 2.0 g/day. Body weight did not change significant-
ly. Serum albumin and transferrin remained normal. Thus, this regimen
induces positive nitrogen balance despite low nitrogen intake.
Utilisation de l'azote chez des malades urmiques nourris par une
perfusion nasogastrique continue. Des malades ayant une insuffisance
rénale sévère ont été nourris de facon continue avec une solution sans
electrolytes contenant des oligosaccharides et 35 g dun mélange de six
acides aminés et de quatre (ou, dans une étude, cinq) analogues
dépourvus d'azote par une sonde nasogastrique de petit calibre reliée a
une pompe. Ils ingéraient également trois petits repas par jour. L'apport
calorique total était en moyenne de 34 kcal/kg (dont 76% était perfuse).
L'apport total en azote était en moyenne de 3,3 g (dont 68% était
perfuse). Néanmoins, Ic bilan d'azote était positif (en moyenne + 1,22
g/jour). Tous les composants de l'excrCtion d'azote se sont abaissés a
des valeurs moyennes inhabituellement basses: apparition d'azote dans
l'urée 1,14 g/jour; azote urinaire non uréique, 0,63 g/jour; azote fécal,
0,48 g/jour. Les besoins de azote pour l'équilibre avec cc régime,
estimés par regression linéaire, étaient de 2,0 g/jour seulement. Le
poids corporel na pas change significativement. L'albumine et Ia
transférine sérique sont restées normales. Ainsi cc régime induit un
bilan de azote positif malgré un faible apport en azote.
We have recently reported results of two studies in which rats
were fed for three weeks by continuous intragastric infusion of
a mixture designed to minimize the rate of production of urinary
waste products. The principal components of the mixture were
sucrose, amino acids, and nitrogen-free analogues of amino
acids. In the first study [11, an unusually high efficiency of
utilization of nitrogen and minerals was demonstrated; weight
gain averaged 3.6 g/day. In the second study [21, rats were
infused with a similar mixture, but 90% of each day's urine
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output was reinfused. Thus renal excretory function was re-
duced to one tenth of normal. Nevertheless, growth and nitro-
gen utilization were the same as in nonreinfused rats.
The purpose of the present study was to explore the applica-
bility of this type of nutritional regimen in chronically uremic
patients. Continuous enteral alimentation via a small-bore naso-
gastric tube was employed, but the patients also were given
three small meals daily to retain some of the pleasure and social
aspects of eating. Food also served as the source of trace metals
and essential fats. Sucrose was replaced by oligosaccharides in
the infusate so as to reduce the likelihood of inducing diarrhea.
A high degree of efficiency of nitrogen utilization was again
demonstrated.
Methods
Seven studies of 3 to 10 weeks duration were conducted in
four patients (three females and one male), aged 48 to 70 years.
The variable duration of the studies was the result of the
patients' desires as to length of hospitalization (except for
patient 3, who was treated as an outpatient). At least 2 months
elapsed between repeat studies in patients 1 and 2. Subjects I
and 2 had chronic glomerulonephritis. Subject 3 had familial
glomerulonephritis. Subject 4 had hypertensive arteriolar neph-
rosclerosis, Before these studies were initiated as well as
between the studies, all but subject 2 were receiving a 20 to 25 g
protein diet supplemented by a mixture [3] of essential amino
acids and their ketoanalogues; subject 2 was on the same diet
without supplements for 8 days. Informed consent was ob-
tained. These studies were approved by the Johns Hopkins
Joint Committee on Clinical Investigation.
Subject 1 was studied three times during the course of her
illness, subject 2 twice, and the other two patients once each. A
silicon rubber tube, size 6.0 French (Keofeed stomach tube,
Hedeco Co., Mountain View, California) was inserted into the
stomach through the nose without the aid of a guide, by
frequent swallowing. The position of the tube was checked
radiographically. The tube was replaced with a new one at least
once a fortnight. Three of the four patients eventually learned to
insert the tube without assistance. The tube was connected to a
constant infusion pump. The composition of the infusate is
shown in Table 1. The sources and preparation of the amino
acids and analogues are given elsewhere [I]. The mixture of
amino acids and analogues was prepared and stored at 40 C.
Oligosaccharides, added on the day of use, were given as Mor-
Rex (Grain Processing Corporation, Muscatine, Iowa), a par-
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Table 1. Composition of mixture infused nasogastrically
Mixture g/day g N/day
Basic amino acids
Ornithine 3.60 0.76
Histidine 1.44 0.39
Lysine 3.11 0.60
Neutral amino acids
Threonine 1.54 0.18
Tryptophan 0.96 0.13
Tyrosine 1.00 0.08
Isoleucine 2.40 0.26
Nitrogen-free analogues
a-ketoisocaproic acid 7.68 —
a-ketoisovaleric acid 6.72 —
(D,L)-a-hydroxy-y-
methylthiobutyric acid 2.88 —
Phenylpyruvic acid 3.66 —
Total 34.99 2.40
Oligosaccharides 400 to 500
Water q.s. 1200 to 1400 ml
tially hydrolyzed cornstarch preparation with a dextrose equiv-
alent of 10. Analysis showed that it contained 0.3 mg of nitrogen
and 1.0 mg of sodium per gram. The final mixture had a pH of
2.5.
The mixture used in the first study and one fourth of the
second study in patient 1 differed from the others in that R,S-a-
keto--methylvaleric acid was used instead of L-isoleucine.
Plasma isoleucine became depressed instead of rising, and
alloisoleucine levels increased markedly. Although neither ill
effects nor deterioration of nitrogen balance resulted, isoleucine
itself was used, beginning 10 days after the start of the second
study in patient 1, and in all of the other studies.
Oligosaccharide intake was varied in response to the patients'
oral intake to maintain total caloric intake close to 34 kcal/kg.
The patients were permitted unlimited quantities of the same
diet they were ingesting previously, namely a diet that would
contain 20 to 25 g of protein of unselected quality and adequate
calories, if taken without supplements. This resulted in the
ingestion of an average of 8.7 kcal/kg of food, containing an
average of 1.17 g of nitrogen. Pyridoxine, 50 mg daily, and a
tablet containing B vitamins and ascorbic acid (Larobec) was
administered daily. All patients required varying amounts of
sodium bicarbonate to prevent acidosis. Neither potassium-
binding resins nor aluminum-containing antacids were given
except in patient 3, who received 4 g of Al(OH)3 daily.
The infusion rate was begun at one fourth of the full rate on
the first day, one half on the second day, three fourths on the
third (and sometimes fourth) day, and at the full rate thereafter.
Preliminary studies in other patients had shown that administra-
tion of the infusion at the full rate from the first day resulted in
diarrhea.
On 5 study days in three of the patients, vomiting occurred.
These days are omitted from balance periods. Although the
tube invariably was ejected during these episodes, no choking
resulted. The patients were all ambulatory and were encour-
aged to walk with the pump attached to a ring stand. On
frequent occasions, they were permitted to remove the tube for
brief periods to allow greater freedom. As noted below, one
patient used a portable pump.
Nitrogen balances during tube-feeding were measured as
previously described [41, and also in two patients (1 and 4) in
control periods while on the oral ketoacid/amino acid supple-
ment [3]. In each nasogastric feeding study two or three balance
periods were obtained between the second and fourth weeks.
Continuous 24-hr urine sample collections were made and
refrigerated as collected. Stools were collected in 3- to 5-day
intervals. Stool markers were not used. No correction was
made for skin loss of nitrogen, nor for the amount of nitrogen
contained in the oligosaccharide preparation (about 150 mgI
day).
Blood samples for chemical analyses were obtained daily.
Plasma for amino acid analysis was obtained at least once a
week at 8 A.M. before breakfast. Plasma amino acids were
measured by automated ion exchange chromatography. All
patients were given an injection of '4C-urea to measure body
dry weight [51.
Results
Caloric intake. An attempt was made to adjust the oligosac-
charide content of the infusate in response to the patients'
voluntary food intake so that total caloric intake met energy
requirements. Average caloric intake during 15 observation
periods in the seven studies was 34.32 kcal/kg (Table 2).
However, total caloric intake varied considerably between
studies. For example, patient 2 ate well during her first study
but had no appetite during her second study a few months later,
by which time renal failure had become more severe. Infused
calories therefore were increased. Total caloric intake in this
patient varied from 34.6 to 44.7 kcal/kg. The fraction of total
caloric intake provided as infusate varied from 55 to 100%
(average 76%).
Nitrogen balance. As shown in Table 2, nitrogen intake from
the infusate averaged 2.17 g/day. Nitrogen intake as protein in
food averaged 1.17 glday. Thus total nitrogen intake averaged
3.34 g/day.
Urea nitrogen appearance, measured as the sum of urea
nitrogen excretion and the rate of change of the body pool of
urea nitrogen, averaged 1.14 g/day. Plasma urea nitrogen fell to
a nadir that averaged 49 mg/dl in the seven studies, despite a 24-
hr urea clearance averaging only 1.8 ml/min. The time course of
average serum urea nitrogen during nasogastric feeding is
shown in Figure 1.
Non-urea urinary nitrogen averaged 0.63 glday (of this, an
average of 0.12 g nitrogen/day was urinary protein). Fecal
nitrogen averaged 0.48 glday. Both of these values are substan-
tially lower than we [41 or others have observed previously in
patients with chronic renal failure.
Nitrogen balance was positive in all but one of the 15 periods
of observation and was correlated closely (r = +0.85, P < 0.01)
with nitrogen intake (Fig. 2). Balance remains significantly
positive if an allowance of 0.35 g/day is made for the difference
between nitrogen ingested in the oligosaccharides and unmea-
sured losses of nitrogen. The intersection of the regression line
with the zero nitrogen balance line gives the estimated required
nitrogen intake for balance on this regimen, 2.0 g/day (2.3 g/day
if corrected as above). Observations in two of these patients on
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Table 2. Results of nitrogen balance measurements
Mean between studies 26.24 8.72 34.32 2.17 1.17 3.34
0 2 4 6
Weeks of nasogastric feeding
Fig. 1. Time course of serum urea nitrogen in patients receiving
continuous nasogastric alimentation, beginning at time zero. The
vertical bars represent 2 x SEM.
an oral ketoacid/amino acid supplement [3] are also shown. On
these regimens, the nitrogen requirement for balance is about 5
glday. We have reported recently a requirement for nitrogen of
about 5 g/day in seven patients receiving a similar ketoacid-
containing oral supplement [61.
Plasma amino acid concentrations. Increases occurred in the
concentration of essential amino acids, measured at 8 A.M.,
during tube-feeding (Fig. 3). These changes were statistically
significant for leucine, phenylalanine, and lysine. The sum of all
eight essential amino acids increased significantly (P < 0.02),
by 18%. Despite the substantial dose of ornithine, the amino
acids of the urea cycle tended to decrease in plasma. The
decrease was statistically significant only for citrulline (—28%,
P < 0.01), an amino acid which is characteristically increased in
plasma of patients with chronic renal failure [7]. Tyrosine rose
toward normal by 16% (P < 0.05) (data not shown).
0.63 1.14 0.48 +1.22
Fig. 2. Nitrogen balance as a function of nitrogen intake in chronic
uremic patients fed by continuous nasogastric infusion. Each patient is
represented by a different symbol, and each point represents one
balance period (see Table 2). Open symbols are observations during
tube-feeding; solid .symbol are observations on a control regimen. The
calculated linear regression line is shown. The intersection of the line
with the horizontal line representing zero balance gives an estimate of
the nitrogen requirement to achieve balance on this regimen, 2 g/day.
These changes are of interest because three of these four
patients were already receiving a supplement containing essen-
tial amino acids plus analogues before the start of tube-feeding,
though at a lower dose (16 g/day). No other plasma amino acid
concentrations changed significantly except for alloisoleucine
in patient 1 (see Methods). As noted in Methods, R,S-ce-keto-/3-
methylvaleric acid was administered initially instead of isoleu-
cine. Plasma alloisoleucine rose, as it does invariably when this
compound is given but more so than usual. Isoleucine levels fell
paradoxically (Fig. 4). Similar observations have been made in
infants given larger doses of this ketoacid but remain unex-
plained [8]. When isoleucine itself replaced the ketoacid, plas-
Nitrogen, g/day
Patient
no.
Study
no.
Balance
period
no.
Calories/kg/day Intake
TF P0 Total NUUN
Urea
N
App
Fecal
N bNTF P0 Total
I I 1 24.81 8.75 33.56 1.98 1.13 3.11 0.42 1.00 0.61 +1.41
2 23.48 9.38 32.86 1.79 1.30 3.09 0.82 1.12 t).77 +0.42
2 1
2
23.13
21.40
8.72
8.89
31.85
30.29
1.87
2.09
1.08
1.55
2.93
3.59
0.45
0.67
1.23
2.57
0.43
0.42
+0.80
+0.67
3 1
2
18.12
20.93
7.79
6.51
25.91
27.44
1.56
2.07
0.89
0.87
2.45
2.94
0.47
0.42
0.62
0.89
0.45
0.40
+0.90
+1.18
2 1 1
2
26.01
29.19
14.19
15.51
40.20
44.70
2.20
2.13
1.78
1.82
3.98
3.95
0.44
0.65
1.32
2.18
0.55
0.50
+1.89
+0.86
2 1
2
3
39.83
34.00
38.32
0.47
0.60
0.00
40.29
34.60
38.32
2.41
1.94
2.18
0.00
0.06
0.00
2.41
2.0
2.18
t).67
0.69
0.81
1.03
0.74
1.10
0.23
0.28
1.09
+0.50
+0.42
—0.37
3 1 1
2
25.87
25.41
13.83
11.39
38.70
36.80
2.43
2.49
2.36
2.02
4.79
4.51
0.65
0.83
0.54
0.63
0.57
0.29
+2.76
+2.47
4 1 1
2
21.61
21.56
9.94
6.20
31.55
27.75
2.49
2.97
1.28
1.49
3.73
4.46
0.75
0.73
1.03
1.17
0.18
0.41
+1.77
+2.67
oral; NUUN, non-urea urinary N; Urea N App, urea N appearance; bN, N balance.Abbreviations: TF, tube-fed; PU,
100
8060
z
40
20
—2
+3
y= 0.89x —1.76
r 0.85, p <0.01
Nasogastr Ic
al imentatiOfl
I
0
0
0
Oral
ketoacids
8
..
N intake, g/day
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Percent change during nasogastric feeding
—30 —20 —10 0 +10 +20 +30 +40
Arginine
Ornithine
Citrulline
Fig. 3. Changes in selected plasma amino acids during nasogastric
alimentation. For each study, the difference between the pretreatment
value and the average of several values observed during tube feeding
was calculated. The mean change was then expressed as a percentage of
the initial value and plotted as shown. Asterisks indicate statistically
significant changes (P < 0.05).
ma isoleucine rose and plasma alloisoleucine gradually fell back
to very low levels.
Serum chemical values. Electrolyte concentrations during
nasogastric alimentation were essentially normal except for
slight hypocalcemia (mean, 8.6 mg/dl) and moderate acidosis
(mean carbon dioxide, 18.5 mM). These values were not signifi-
cantly different from values observed at the start of tube
feeding. The anion gap averaged 18.4 mM initially and 18.5 mM
during tube-feeding, indicating that no accumulation of keto-
acids occurred. Serum phosphate averaged 3.0 mg/dl, signifi-
cantly lower than the pretreatment mean of 4.2 mg/dl (P < 0.01)
and was distinctly subnormal in six observation periods. In
three of these periods a phosphate supplement (dibasic sodium
phosphate, 15 mmoles) was given as a single dose because
serum phosphate briefly fell below 2 mg/dl.
None of these patients exhibited protein malnutrition at the
start of nasogastric feeding, as indicated by the serum albumin
and transferrin levels shown in Table 3. Initial serum albumin
averaged 3.8 g/dl before the start of tube-feeding and did not
change significantly, during tube feeding. Serum transferrin
averaged 304 mg/dl at the start and did not change significantly.
Triglycerides (not shown) averaged 140 mg/dl before tube
feeding and 165 mg/dl at the end of tube feeding, also a
statistically insignificant change. Body weight increased on the
average but not significantly.
E.ffrct on rate of progression of renal insufficiency. In three of
the four patients, no detectable change in the rate of fall in
estimated GFR or reciprocal serum creatinine 191 occurred
during tube feeding. In subject 3, the decline of reciprocal
serum creatinine concentration ceased during 10 weeks of tube-
feeding (Fig. 5). Twenty-four-hour clearances were available
only during the first 2 weeks of this time and showed no
significant decline. Thereafter, he was treated in the same
manner as an outpatient, with the aid of a portable constant
infusion pump (Cormed Inc., Middleport, New York). At the
end of 10 weeks of tube-feeding, he chose to resume a normal
Oral TF Oral TF
Fig. 4. Plasma isoleucine and alloisoleucine in patient 1 during a 6-
month interval. Nasogastric alimentation was performed during the
periods labelled TF. At other times she received a 20 to 25 g protein diet
supplemented by an oral ketoacid/amino acid mixture. Racemic
KMVA, a mixture of the ketoanalogues of isoleucine and alloisoleu-
cine, was present in the nasogastric infusate at a higher dosage (0.5
mmoles/kg/day) than in the oral supplement (0.2 mmoles/kg/day).
Plasma alloisoleucine (normally present only in traces) was 20 to 40 /.M
during oral supplementation and rose to much higher levels during
nasogastric alimentation: concurrently, plasma isoleucine fell during
both periods of tube-feeding. KMVA was replaced with L-isoleucine
itself in the nasogastric infusate during the last 5 weeks of the second
period of tube-feeding; plasma alloisoleucine gradually fell toward trace
levels and isoleucine rose promptly to normal levels.
diet. Tube-feeding was discontinued and he soon entered regu-
lar dialysis treatment.
Discussion
These results show that continuous intragastric administra-
tion of a mixture containing carbohydrate, amino acid ana-
logues, and amino acids can reduce the rate of urinary excretion
of waste products and lead to unusually efficient utilization of
administered nitrogen in uremic patients, as we have observed
in animals [1, 21.
Since there was no evidence for protein malnutrition in these
subjects at the start of the studies, the results clearly cannot be
attributed to restoration of protein stores in protein-depleted
individuals.
No attempt was made in the present study to minimize the
urinary output of non-nitrogenous waste products, as we did in
rats. The fall in serum phosphate that occurred in the patients
presumably reflects an intake too low to compensate for
obligatory losses plus the utilization of phosphate for anabolism
in conjunction with positive nitrogen balance. A fall in serum
phosphate has been demonstrated in uremic patients during
parenteral alimentation with phosphate-free solutions [101.
To determine what factors contributed to the low rates of
nitrogen output observed in this study, it is instructive to
compare the results of this study with three previous studies
from this laboratory: two in which essential amino acid and/or
150
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Histidine
EAA
100
Alloisoleucine
50
1*
Isoleucine
Sept Oct
E 0.0
Nov Dec Jan Feb
ketoacid supplements plus glycine were added to virtually
protein-free diets [4, 11], and one in which similar supplements
were added to a 25-g protein diet [12]. In these other studies,
nitrogen intake was greater than in the present study (about 4 g/
day), but nitrogen balance was less positive or neutral. Despite
the fact that these comparisons are not statistically valid, they
offer some clues in the interpretation of the results.
Urea nitrogen appearance is lowest in the present study (1.14
g/day), but was higher during oral intake including glycine
without protein [4, 11], and was yet higher in the study in which
protein was fed [121. Thus the low rate of urea nitrogen
appearance during nasogastric feeding may be attributable in
part to the low dietary intake of whole protein and in part to the
nasogastric alimentation itself. Suppression of nocturnal gluco-
neogenesis may be a factor.
Non-urea urinary nitrogen was the same in the two previous
studies whether dietary protein or glycine was given. During
nasogastric feeding it is lower by almost 0.3 g/day, Part of this
difference is attributable to lower creatinine output in the tube-
fed patients, which may, in turn, reflect their more severe renal
failure. Recent evidence indicates that creatinine output de-
creases as renal failure progresses, not because of altered
creatinine production, but because of increasing creatinine
degradation [13]. Uric acid output was also somewhat lower in
tube-fed patients, probably because of lesser purine intake.
Fecal nitrogen was substantially higher in the group receiving
protein [12] than in the two groups receiving little protein. The
larger fecal residue on higher protein intake is probably
responsible.
Since most of the patients in these previous studies were also
receiving ketoacids (though at a somewhat lower dosage), it
seems unlikely that the lower nitrogen requirement seen here is
attributable to ketoacid administration. Further studies will be
required to determine whether or not comparable nitrogen
conservation can be induced by enteral alimentation for less
than 24 hr/day. Feeding this same diet by mouth would be
impractical because of its relatively high acidity (pH 2.5).
"Obligatory" excretion rates of nitrogenous waste products
have been defined traditionally as those rates observed on a
protein-free diet, on the presumption that such a regimen would
produce the lowest possible rates. In man, urea nitrogen
excretion falls to about 2.5 g/day and total nitrogen excretion to
about 4 g/day on a protein-free diet [14]. Both of these rates are
approximately twice as high as those observed in the present
study. Not all of the difference can be attributed to continuous
nasogastric administration of this particular nutrient mixture,
Patient
no.
age, sex
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Table 3. Changes in body weight and serum proteins during nasogastric alimentation
Study no.,
duration
(days)
GFR Weight Albumin Transferrin
mI/mm kg gIdi mg/dI
335
373
+ 38
374
370
—4
333
358
1(17)
Female,
78 yr
2 (46)
3 (19)
2.9
2.5
1.3
Initial
Final
Change
Initial
Final
Change
Initial
Final
Change
72.5
76.3
+3.8
72.9
75.6
+2.7
71.7
71.1
—0.6
4.!
3.8
—0.3
4.2
4.0
—0.2
3.6
3.6
0.0
2 1(58)
Female,
62 yr
2(38)
6.5
1.8
Initial
Final
Change
Initial
Final
Change
53.0
57.2
+3.8
56.7
54.2
—2.5
3.4
3.3
—0.1
3.3
3.7
+0.4
306
264
—42
181
341
+160
3 1(70)
Male,
48yr
3.6 Initial
Final
Change
66.4
72.0
+5.6
3.6
4.1
+0.5
229
227
—2
4 1(45)
Female,
71 yr
1.5 Initial
Final
Change
77.7
82.1
+4.4
4.1
3.6
—0.5
370
280
—90
Mean initial value between studies SEM 3.8 304
Mean initial value between patients SEM 3.8 298
Mean change between studies SEM +2.5 0.0 12
Mean change between patients SEM +3.2 +0.6 3
±31
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Fig. 5. Progression of renal insufficiency, as measured by the rate of
decline of reciprocal serum creatinine concentration, arrested in one
patient during nasogastric alimentat ion. Progression was unaffected in
the others.
because, as has been documented in many other studies [71,
chronic uremia itself tends to reduce excretion rates of creati-
nine, ammonia, and uric acid, the three main components of
non-urea urinary nitrogen. Furthermore, protein restriction
plus supplementation with essential amino acids and/or amino
acid analogues reduces urea appearance 171.
Guillot et al [15] have recently described results of long-term
enteral feeding in children with various forms of renal disease,
including three patients with renal failure treated for 4 to 45
months. Protein intake (as casein hydrolysate or whole protein)
was 1.5 to 2 glkg. One patient had acute renal failure and
responded well. Another required chronic peritoneal dialysis.
Two of the three children grew at normal rates. No attempt was
made to minimize the urinary excretion of waste products;
instead, the rationale of the study was to ensure an adequate
intake of nutrients.
Chronic renal failure in children is difficult to treat and might
well be a fruitful area for further investigation of this technique.
Portable infusion pumps are available that can permit nearly
normal activity. In infants, a gastrostomy route might be
preferable. In adults, the practical utility of this technique may
be limited to patients who are awaiting the maturation of an
arteriovenous fistula or who are temporarily not candidates for
dialysis for one reason or another.
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